THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View Raised
Tenet Healthcare (THC) delivered robust third-quarter 2026 results with adjusted EPS of $6.64, up 79.5% year-over-year and beating estimates by 44.4%. Revenues grew 6.5% to $5.6 billion, driven by higher admissions, pricing strength, and disciplined cost management. The company raised its full-year 2026 adjusted EPS guidance to $22.05-$23.01 and EBITDA guidance to $5.05-$5.2 billion. Hospital EBITDA surged 34.8% to $818 million, while the company generated $1.1 billion in free cash flow and repurchased $255 million in shares.